AU1698997A - Tocolytic oxytocin receptor antagonists - Google Patents
Tocolytic oxytocin receptor antagonistsInfo
- Publication number
- AU1698997A AU1698997A AU16989/97A AU1698997A AU1698997A AU 1698997 A AU1698997 A AU 1698997A AU 16989/97 A AU16989/97 A AU 16989/97A AU 1698997 A AU1698997 A AU 1698997A AU 1698997 A AU1698997 A AU 1698997A
- Authority
- AU
- Australia
- Prior art keywords
- receptor antagonists
- oxytocin receptor
- tocolytic oxytocin
- tocolytic
- antagonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1003496P | 1996-01-16 | 1996-01-16 | |
| US010034 | 1996-01-16 | ||
| GB9605701 | 1996-03-19 | ||
| GBGB9605701.3A GB9605701D0 (en) | 1996-03-19 | 1996-03-19 | Tocolytic oxytocin receptor antagonists |
| PCT/US1997/000571 WO1997025992A1 (en) | 1996-01-16 | 1997-01-13 | Tocolytic oxytocin receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1698997A true AU1698997A (en) | 1997-08-11 |
Family
ID=26308952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU16989/97A Abandoned AU1698997A (en) | 1996-01-16 | 1997-01-13 | Tocolytic oxytocin receptor antagonists |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU1698997A (en) |
| WO (1) | WO1997025992A1 (en) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0805681A4 (en) * | 1995-01-24 | 1998-05-06 | Merck & Co Inc | TOCOLYTIC ANTAGONISTS OF OXYTOCIN RECEPTORS |
| US7045519B2 (en) | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| US7326700B2 (en) | 2001-04-12 | 2008-02-05 | Wyeth | Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
| US7064120B2 (en) | 2001-04-12 | 2006-06-20 | Wyeth | Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| US6977254B2 (en) | 2001-04-12 | 2005-12-20 | Wyeth | Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
| US6900200B2 (en) | 2001-04-12 | 2005-05-31 | Wyeth | Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| US7202239B2 (en) | 2001-04-12 | 2007-04-10 | Wyeth | Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists |
| US7109193B2 (en) | 2001-04-12 | 2006-09-19 | Wyeth | Tricyclic diazepines tocolytic oxytocin receptor antagonists |
| US7022699B2 (en) | 2001-04-12 | 2006-04-04 | Wyeth | Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
| ES2193875B2 (en) | 2002-04-09 | 2005-03-01 | Laboratorios Del Dr. Esteve, S.A. | DERIVATIVES OF BENZOXAZINONA, ITS PREPARATION AND ITS APPLICATION AS MEDICATIONS. |
| JP4697962B2 (en) | 2003-02-13 | 2011-06-08 | ウェルスタット セラピューティクス コーポレイション | Compounds for the treatment of metabolic disorders |
| KR20080089453A (en) | 2006-01-25 | 2008-10-06 | 웰스태트 테러퓨틱스 코포레이션 | Compounds for the treatment of metabolic disorders |
| US7820721B2 (en) | 2006-01-25 | 2010-10-26 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| KR20080097418A (en) | 2006-02-02 | 2008-11-05 | 웰스태트 테러퓨틱스 코포레이션 | Compounds for the treatment of metabolic disorders |
| ES2374952T3 (en) | 2006-12-06 | 2012-02-23 | Glaxosmithkline Llc | BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS. |
| MX344264B (en) | 2009-02-13 | 2016-12-09 | Boehringer Ingelheim Int Gmbh * | SGLT-2 INHIBITOR FOR THE TREATMENT OF MELLITUS DIABETES TYPE 1, MELLITUS DIABETES TYPE 2, TOLERANCE DETERIORATED TO GLUCOSE OR HYPERGLUCEMIA. |
| HK1215398A1 (en) | 2013-04-05 | 2016-08-26 | 勃林格殷格翰国际有限公司 | Therapeutic uses of empagliflozin |
| US11813275B2 (en) | 2013-04-05 | 2023-11-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| US20140303097A1 (en) | 2013-04-05 | 2014-10-09 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| CA2812519A1 (en) | 2013-04-05 | 2014-10-05 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| PT2986304T (en) | 2013-04-18 | 2022-02-25 | Boehringer Ingelheim Int | Pharmaceutical composition, methods for treating and uses thereof |
| MA46742A (en) | 2016-11-10 | 2019-09-18 | Boehringer Ingelheim Int | PHARMACEUTICAL COMPOSITION, METHODS OF TREATMENT AND THEIR USES |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4344945A (en) * | 1980-03-10 | 1982-08-17 | Kyowa Hakko Kogyo Co., Ltd. | Piperidine derivatives |
-
1997
- 1997-01-13 AU AU16989/97A patent/AU1698997A/en not_active Abandoned
- 1997-01-13 WO PCT/US1997/000571 patent/WO1997025992A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997025992A1 (en) | 1997-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3633997A (en) | Chemokine receptor antagonists | |
| AU1698997A (en) | Tocolytic oxytocin receptor antagonists | |
| AU1765695A (en) | Non-peptidyl tachykinin receptor antagonists | |
| AU1842995A (en) | N-acylpiperidine tachykinin antagonists | |
| AU4343796A (en) | Tachykinin antagonists | |
| AU3579897A (en) | Fibrinogen receptor antagonists | |
| AU2524995A (en) | Neurokinine (tachykinine) antagonists | |
| AU4746297A (en) | Vitronectin receptor antagonists | |
| AU3899997A (en) | Muscarinic antagonists | |
| AU7692996A (en) | Receptor antagonists | |
| AU2242197A (en) | Benzimidzolyl neuropeptide y receptor antagonists | |
| IL135797A0 (en) | Thrombin receptor antagonists | |
| AU8673198A (en) | Il-8 receptor antagonists | |
| AU6856796A (en) | Des-arg9-bk antagonists | |
| AU4763896A (en) | Tocolytic oxytocin receptor antagonists | |
| AU5764298A (en) | Tachykinin antagonists | |
| AU4999897A (en) | Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists | |
| AU6435098A (en) | Il-8 receptor antagonists | |
| GB9813103D0 (en) | Tocolytic oxytocin receptor antagonists | |
| AU1574995A (en) | Tachykinins antagonists | |
| AU6826598A (en) | Endothelin-receptor antagonists | |
| GB9704025D0 (en) | Tocolytic oxytocin receptor antagonists | |
| AU6826498A (en) | Endotholin receptor antagonists | |
| AU5239898A (en) | Phenyl spiroethercycloalkyl tachykinin receptor antagonists | |
| AU6826698A (en) | Endothelin receptor antagonists |